AESARA Europe hosted a webinar on the EU HTA regulation last week, covering key fundamentals and the latest developments. Featuring engaging discussions and insightful questions from our industry partners, our EU HTA experts distilled three essential takeaways, to help biotech and pharma innovators prepare their JCA submission strategies.
